NASDAQ : RIGL
Rigel Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 51.45 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 961.08M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Rigel Pharmaceuticals, Inc. (RIGL) reported revenue of 276.79M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 276.52M | 294.02M | 179.28M | 115.78M | 115.74M | 138.74M |
| Other Revenue | 265.00K | 265.00K | 1.10M | |||
| Revenue | 276.79M | 294.28M | 179.28M | 116.88M | 115.74M | 138.74M |
| Cost of Revenue | 67.51M | 52.92M | 42.03M | 31.63M | 62.02M | 66.32M |
| Gross Profit | 209.27M | 241.37M | 137.25M | 85.25M | 53.72M | 72.42M |
| Selling, General & Admin | 122.22M | 115.90M | 113.06M | 105.74M | 112.45M | 91.89M |
| Operating Expenses | 122.22M | 115.90M | 113.06M | 105.74M | 112.45M | 91.89M |
| Operating Income | 87.05M | 125.47M | 24.19M | -20.49M | -58.73M | -19.48M |
| Interest Expense | -5.80M | -7.32M | -7.92M | -6.87M | -3.71M | -4.86M |
| Interest & Investment Income | 4.33M | 3.68M | 2.09M | 2.27M | 684.00K | 47.00K |
| EBT Excluding Unusual Items | 85.58M | 121.83M | 18.37M | -25.09M | -61.75M | -24.29M |
| Merger & Restructuring Charges | -1.32M | -3.52M | ||||
| Other Unusual Items | 4.50M | 10.50M | ||||
| Pretax Income | 85.58M | 121.83M | 18.37M | -25.09M | -58.57M | -17.31M |
| Income Tax Expense | -236.33M | -245.20M | 881.00K | 605.00K | ||
| Net Income | 321.91M | 367.02M | 17.48M | -25.09M | -58.57M | -17.91M |
| Net Income to Common | 321.91M | 367.02M | 17.48M | -25.09M | -58.57M | -17.91M |
| Shares Outstanding (Basic) | 18.30M | 17.99M | 17.58M | 17.40M | 17.05M | 17.05M |
| Shares Outstanding (Diluted) | 19.57M | 18.84M | 17.69M | 17.40M | 17.05M | 17.05M |
| EPS (Basic) | 17.59 | 20.40 | 0.99 | -1.44 | -3.44 | -1.05 |
| EPS (Diluted) | 16.45 | 19.48 | 0.99 | -1.44 | -3.44 | -1.05 |
| Free Cash Flow | 79.39M | 75.66M | 31.43M | -5.74M | -74.21M | 5.25M |
| Free Cash Flow Per Share | 4.06 | 4.02 | 1.78 | -0.33 | -4.35 | 0.31 |
| Gross Margin | 75.61% | 82.02% | 76.56% | 72.94% | 46.41% | 52.20% |
| Operating Margin | 31.45% | 42.63% | 13.49% | -17.53% | -50.74% | -14.04% |
| Profit Margin | 116.30% | 124.72% | 9.75% | -21.47% | -50.61% | -12.91% |
| Free Cash Flow Margin | 28.68% | 25.71% | 17.53% | -4.91% | -64.11% | 3.79% |
| EBITDA | 89.70M | 127.88M | 26.42M | -19.25M | -57.73M | -18.31M |
| EBITDA Margin | 32.41% | 43.45% | 14.74% | -16.47% | -49.88% | -13.20% |
| D&A For EBITDA | 2.65M | 2.42M | 2.23M | 1.24M | 998.00K | 1.16M |
| EBIT | 87.05M | 125.47M | 24.19M | -20.49M | -58.73M | -19.48M |
| EBIT Margin | 31.45% | 42.63% | 13.49% | -17.53% | -50.74% | -14.04% |
| Effective Tax Rate | 4.80% | |||||
| Revenue as Reported | 276.79M | 294.28M | 179.28M | 116.88M | 120.24M | 149.24M |
| Advertising Expenses | 2.30M | 2.10M | 3.10M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 60.82M | 40.58M | 56.75M | 32.79M | 24.46M | 18.89M |
| Short-Term Investments | 34.51M | 114.38M | 20.57M | 24.15M | 33.75M | 106.08M |
| Cash & Short-Term Investments | 95.33M | 154.96M | 77.32M | 56.93M | 58.21M | 124.97M |
| Receivables | 56.04M | 51.76M | 41.62M | 30.55M | 40.32M | 15.47M |
| Inventory | 24.15M | 23.36M | 9.76M | 5.52M | 17.38M | 6.62M |
| Prepaid Expenses | 4.99M | 4.89M | 1.89M | 6.26M | 7.41M | |
| Other Current Assets | 5.03M | 5.21M | 4.52M | |||
| Total Current Assets | 185.53M | 240.17M | 135.10M | 99.27M | 115.90M | 154.47M |
| Property, Plant & Equipment | 647.00K | 950.00K | 338.00K | 1.03M | 2.79M | 11.89M |
| Other Intangible Assets | 93.88M | 24.75M | 27.10M | 13.88M | 14.95M | |
| Long-Term Deferred Tax Assets | 238.07M | 245.85M | ||||
| Other Long-Term Assets | 2.94M | 1.88M | 1.44M | 3.06M | 640.00K | 974.00K |
| Total Assets | 521.07M | 513.59M | 163.98M | 117.22M | 134.28M | 167.33M |
| Accounts Payable | 4.01M | 7.19M | 3.34M | 7.14M | 22.51M | 3.79M |
| Accrued Expenses | 46.31M | 50.46M | 46.33M | 29.28M | 31.91M | 31.75M |
| Current Portion of Long-Term Debt | 39.24M | 29.81M | 7.27M | 10.87M | 3.94M | 7.97M |
| Current Portion of Leases | 656.00K | 614.00K | 285.00K | 692.00K | 1.13M | 9.89M |
| Current Unearned Revenue | 1.35M | 1.35M | 1.35M | 1.37M | 2.60M | |
| Other Current Liabilities | 5.38M | 9.81M | 4.72M | 3.93M | 4.36M | 7.55M |
| Total Current Liabilities | 95.59M | 99.24M | 63.30M | 53.27M | 65.21M | 63.55M |
| Long-Term Debt | 22.48M | 92.39M | 92.32M | 81.71M | 72.64M | |
| Long-Term Leases | 58.00K | 395.00K | 285.00K | 972.00K | 759.00K | |
| Other Long-Term Liabilities | 5.00M | |||||
| Total Liabilities | 95.64M | 122.11M | 160.69M | 145.87M | 147.90M | 136.95M |
| Common Stock | 18.00K | 18.00K | 18.00K | 17.00K | 174.00K | 172.00K |
| Additional Paid-In Capital | 1.42B | 1.41B | 1.39B | 1.38B | 1.37B | 1.35B |
| Retained Earnings | -997.10M | -1.02B | -1.39B | -1.41B | -1.38B | -1.32B |
| Comprehensive Income & Other | -148.00K | 181.00K | 10.00K | 8.00K | -153.00K | -102.00K |
| Shareholders' Equity | 425.42M | 391.48M | 3.29M | -28.64M | -13.62M | 30.37M |
| Total Liabilities & Equity | 521.07M | 513.59M | 163.98M | 117.22M | 134.28M | 167.33M |
| Total Debt | 39.95M | 53.30M | 99.95M | 104.17M | 87.75M | 91.27M |
| Net Cash (Debt) | 55.38M | 101.65M | -22.62M | -47.23M | -29.55M | 33.70M |
| Net Cash Per Share | 2.83 | 5.40 | -1.28 | -2.71 | -1.73 | 1.98 |
| Filing Date Shares Outstanding | 18.68M | 18.47M | 17.86M | 17.54M | 17.37M | 17.17M |
| Total Common Shares Outstanding | 18.65M | 18.31M | 17.71M | 17.48M | 17.34M | 17.16M |
| Working Capital | 89.94M | 140.93M | 71.80M | 46.00M | 50.69M | 90.91M |
| Book Value Per Share | 22.81 | 21.38 | 0.19 | -1.64 | -0.79 | 1.77 |
| Tangible Book Value | 331.54M | 366.73M | -23.81M | -42.52M | -28.57M | 30.37M |
| Tangible Book Value Per Share | 17.77 | 20.03 | -1.34 | -2.43 | -1.65 | 1.77 |
| Machinery | 1.83M | 9.48M | 16.04M | |||
| Construction In Progress | 691.00K | |||||
| Leasehold Improvements | 2.11M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 321.91M | 367.02M | 17.48M | -25.09M | -58.57M | -17.91M |
| Depreciation & Amortization | 2.65M | 2.42M | 2.23M | 1.24M | 998.00K | 1.16M |
| Loss (Gain) From Sale of Assets | -79.00K | 266.00K | -138.00K | |||
| Loss (Gain) From Sale of Investments | -915.00K | -1.15M | -709.00K | -479.00K | -63.00K | 287.00K |
| Stock-Based Compensation | 16.41M | 12.71M | 12.39M | 8.81M | 12.38M | 9.49M |
| Other Operating Activities | -237.86M | -285.83M | 682.00K | 3.14M | ||
| Change in Accounts Receivable | -16.13M | -10.15M | -11.06M | 9.77M | -24.85M | 501.00K |
| Change in Inventory | -2.52M | -5.63M | 764.00K | 1.17M | -2.38M | -4.88M |
| Change in Accounts Payable | -3.28M | 3.85M | -3.80M | -366.00K | 3.79M | 41.00K |
| Change in Unearned Revenue | -1.23M | -422.00K | ||||
| Change in Other Net Operating Assets | -872.00K | -7.58M | 14.26M | -1.06M | -4.38M | 14.47M |
| Operating Cash Flow | 79.39M | 75.66M | 31.47M | -5.74M | -73.76M | 5.88M |
| Capital Expenditures | -36.00K | -450.00K | -627.00K | |||
| Sale of Property, Plant & Equipment | 98.00K | 259.00K | 893.00K | |||
| Sale (Purchase) of Intangibles | -70.35M | -360.00K | -15.00M | |||
| Investment in Securities | 21.29M | -92.36M | 4.43M | 10.44M | 72.33M | -79.41M |
| Investing Cash Flow | -49.06M | -92.36M | 4.13M | -4.30M | 72.78M | -80.04M |
| Long-Term Debt Issued | 19.95M | 19.54M | ||||
| Long-Term Debt Repaid | -7.50M | |||||
| Net Debt Issued (Repaid) | -22.75M | -7.50M | 19.95M | 19.54M | ||
| Issuance of Common Stock | 9.38M | 8.10M | 1.96M | 1.05M | 2.12M | 62.67M |
| Other Financing Activities | -5.30M | -13.61M | -2.63M | -15.12M | ||
| Financing Cash Flow | -22.92M | 601.00K | -11.64M | 18.37M | 6.55M | 62.67M |
| Net Cash Flow | 7.41M | -16.11M | 23.96M | 8.33M | 5.57M | -11.48M |
| Free Cash Flow | 79.39M | 75.66M | 31.43M | -5.74M | -74.21M | 5.25M |
| Free Cash Flow Margin | 28.68% | 25.71% | 17.53% | -4.91% | -64.11% | 3.79% |
| Free Cash Flow Per Share | 4.06 | 4.02 | 1.78 | -0.33 | -4.35 | 0.31 |
| Levered Free Cash Flow | -31.76M | 74.61M | 22.99M | -25.13M | -39.83M | 10.44M |
| Unlevered Free Cash Flow | -28.13M | 79.18M | 27.93M | -20.84M | -37.52M | 13.47M |
| Cash Interest Paid | 8.20M | 6.57M | 7.04M | 5.85M | 2.50M | 1.50M |
| Cash Income Tax Paid | 1.06M | 1.06M | 331.00K | 81.00K | ||
| Change in Working Capital | -22.81M | -19.51M | 153.00K | 9.52M | -29.05M | 9.72M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 958.46M | 777.42M | 296.28M | 252.84M | 259.25M | 453.17M |
| Enterprise Value | 903.08M | 701.16M | 335.38M | 294.87M | 269.29M | 402.60M |
| Last Close Price | 51.31 | 42.83 | 16.82 | 14.50 | 15.00 | 26.50 |
| PE Ratio | 3.12 | 2.12 | 16.95 | |||
| Forward PE | 16.00 | 10.49 | 17.39 | |||
| PS Ratio | 3.46 | 2.64 | 1.65 | 2.16 | 2.24 | 3.27 |
| PB Ratio | 2.25 | 1.99 | 90.11 | -8.83 | -19.04 | 14.92 |
| P/TBV Ratio | 2.89 | 2.12 | 14.92 | |||
| P/FCF Ratio | 12.07 | 10.28 | 9.43 | 86.30 | ||
| P/OCF Ratio | 12.07 | 10.28 | 9.41 | 77.09 | ||
| EV/Sales Ratio | 3.26 | 2.38 | 1.87 | 2.52 | 2.33 | 2.90 |
| EV/EBITDA Ratio | 10.07 | 5.48 | 12.69 | |||
| EV/EBIT Ratio | 10.37 | 5.59 | 13.86 | |||
| EV/FCF Ratio | 11.38 | 9.27 | 10.67 | 76.67 | ||
| Debt / Equity Ratio | 0.09 | 0.14 | 30.40 | -3.64 | -6.45 | 3.00 |
| Debt / EBITDA Ratio | 0.44 | 0.41 | 3.68 | |||
| Debt / FCF Ratio | 0.50 | 0.70 | 3.18 | 17.38 | ||
| Net Debt / Equity Ratio | -0.13 | -0.26 | 6.88 | -1.65 | -2.17 | -1.11 |
| Net Debt / EBITDA Ratio | -0.62 | -0.80 | 0.86 | -2.45 | -0.51 | 1.84 |
| Net Debt / FCF Ratio | -0.70 | -1.34 | 0.72 | -8.22 | -0.40 | -6.42 |
| Asset Turnover | 0.76 | 0.87 | 1.27 | 0.93 | 0.77 | 1.00 |
| Inventory Turnover | 3.38 | 3.20 | 5.50 | 2.76 | 5.17 | 10.82 |
| Quick Ratio | 1.58 | 2.08 | 1.88 | 1.64 | 1.51 | 2.21 |
| Current Ratio | 1.94 | 2.42 | 2.13 | 1.86 | 1.78 | 2.43 |
| Return on Equity (ROE) | 126.90% | 185.94% | -699.04% | -55.63% | ||
| Return on Assets (ROA) | 14.95% | 23.15% | 10.75% | -10.18% | -24.34% | -8.77% |
| Return on Invested Capital (ROIC) | 26.02% | 79.47% | 51.25% | -30.81% | -85.03% | |
| Return on Capital Employed (ROCE) | 20.50% | 30.30% | 24.00% | -32.00% | -85.00% | -18.80% |
| Earnings Yield | 32.06% | 47.21% | 5.90% | -9.92% | -22.59% | -3.95% |
| FCF Yield | 8.28% | 9.73% | 10.61% | -2.27% | -28.62% | 1.16% |
| Buyback Yield / Dilution | -8.67% | -6.52% | -1.64% | -2.07% | 0.00% | -1.03% |